I don’t agree with the FDA being the problem. If we had
I don’t agree with the FDA being the problem. If we had the numbers needed for efficacy of our trial we wouldn’t be denied. Our trial wasn’t designed properly to succeed and our chance to change our primary end point flew under the radar of the review of the DSMB who had our future in their hands and told us we would succeed and to continue with that 42 day addition to our end point. Even though that had no meaningful ending for us if used. We have learned some expensive lessons.
We can’t blame the FDA for results that for many reasons didn’t make the grade of acceptance for a BLA or even a EUA so far. All hope of the EUA is still possible and maybe just needs a few more patients to reach the predicted 70 needed patients to have an effect on the trial efficacy in a few areas that allow us to achieve that EUA. All is not lost yet. We have those equalizing stats in the 55 patients so far according to Nader stating we had a 16.7% mortality in that group. We just need another 15-20 patients and 28 days then we send those results forward and see if we qualify for the EUA.
This seems like what is happening from my view. We sure are not in a hurry to get more trials started. The waiting game starts to look intentional for Cytodyn and even the FDA. Maybe to see if we can add the additional patients to our CD-15 trial because our trail size was so small. I for one, Can’t wait to see if it’s true that the FDA will add the extension to our critical section of our trial and get the EUA.
Definition of extension is what? It’s what I expect to happen if a extension is granted.
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...
Continue Reading
They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...
Continue Reading
Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...
Continue Reading
A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...
Continue Reading
Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...
Continue Reading
An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...
Continue Reading
Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...
Continue Reading
Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...
Continue Reading
Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...
Continue Reading
They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...
Continue Reading
Top 5 Most Recently Viewed Articles
ICF Announces Leadership Changes Supportive of Future Growth ICF, a leading global solutions and technology provider, is putting significant changes in place as they move forward. Barry Broadus, the company’s chief financial officer (CFO), has informed ICF of his intention to retire after a commendable career that spans over 40 years in finance. His retirement is set...
Continue Reading
Strategic Insights from Alcoa's Earnings Call During its recent earnings call, Alcoa Corporation (NYSE: AA), a prominent player in the aluminum industry, shared valuable insights regarding its strategic initiatives and financial performance. The company is concentrating on reducing costs, optimizing its portfolio, and enhancing sustainability in aluminum production. A key...
Continue Reading
Gurbir S. Grewal Joins Milbank Law Firm Milbank LLP is thrilled to announce that Gurbir S. Grewal, formerly the Director of the SEC's Division of Enforcement, is now a partner at the firm. He will bring his extensive experience and legal acumen to enhance the Litigation & Arbitration group at Milbank. A Distinguished Career at the SEC Gurbir Grewal has a commendable...
Continue Reading
Empowering Primary Care: A New Approach to Pulmonary Hypertension American Lung Association and Pulmonary Hypertension Association introduce new guidance for primary care physicians. Pulmonary hypertension (PH) is a serious condition characterized by high blood pressure in the blood vessels connecting the lungs and heart. Although it is relatively uncommon, untreated...
Continue Reading
Carputty Launches Flexloan for Enhanced Auto Financing Access Carputty, a trailblazing fintech company, is taking significant strides in revolutionizing vehicle financing with the introduction of Flexloan. This new product is set to dramatically expand Carputty’s addressable market, providing a fresh financing option in collaboration with Westlake Direct, a division of...
Continue Reading